Drug application
REGADENOSON (REGADENOSON)
Drugs@FDA ANDA 212806 · MEITHEAL
Key facts
| Drug name | REGADENOSON |
|---|---|
| Active ingredients | REGADENOSON |
| Application type | ANDA |
| Application number | 212806 |
| Company | MEITHEAL |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | 0.4MG/5ML (0.08MG/ML) |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Apr 11, 2022 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.